Compare AXTA & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXTA | STVN |
|---|---|---|
| Founded | 1910 | 1949 |
| Country | United States | Italy |
| Employees | 12300 | N/A |
| Industry | Paints/Coatings | Containers/Packaging |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 4.2B |
| IPO Year | 2014 | 2021 |
| Metric | AXTA | STVN |
|---|---|---|
| Price | $27.46 | $14.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 3 |
| Target Price | ★ $36.71 | $25.67 |
| AVG Volume (30 Days) | ★ 2.6M | 565.5K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.43% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.74 | N/A |
| Revenue | ★ $5,117,000,000.00 | N/A |
| Revenue This Year | $3.56 | $10.26 |
| Revenue Next Year | $2.93 | $10.02 |
| P/E Ratio | ★ $16.00 | $27.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $26.28 | $13.91 |
| 52 Week High | $35.72 | $28.00 |
| Indicator | AXTA | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 18.41 | 43.56 |
| Support Level | $27.43 | $14.03 |
| Resistance Level | $31.01 | $17.14 |
| Average True Range (ATR) | 0.98 | 0.87 |
| MACD | -0.59 | 0.04 |
| Stochastic Oscillator | 0.54 | 25.11 |
Axalta Coating Systems Ltd is a manufacturer, marketer, and distributor of high-performance coatings systems. It operates in two segments: Performance Coatings and Mobility Coatings. The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial, and the Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The majority of its revenue is generated from the Mobility Coatings segment. Geographically, the company generates maximum revenue from the Europe, Middle East and Africa (EMEA) region, followed by North America, Asia Pacific, and Latin America.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.